Talimogene laherparepvec monotherapy, an elegant alternative to systemic immunotherapy for the treatment of early metastatic melanoma.

Talimogene laherparepvec monotherapy, an elegant alternative to systemic immunotherapy for the treatment of early metastatic melanoma. Br J Dermatol. 2019 Jul;181(1):20-21 Authors: Franke V PMID: 31259401 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31259401?dopt=Abstract

Source: The British Journal of Dermatology - June 30, 2019 Category: Dermatology Authors: Franke V Tags: Br J Dermatol Source Type: research